Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Vaxcyte, Inc. PCVX

Set alert

Price alert · PCVX

All alert types
60.62 USD -1.41 -2.27%

At close · Nov 2

60.62 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
60.58 × 2
Ask
60.62 × 2
60.15 Day range 62.87
39.87 52-week range 90.75
YTD
+31.38%
1 year
+33.88%
Open
61.88
Prev close
62.03
Mkt cap
9.54B
Vol
1.32M
Avg vol
2.09M
EPS
-7.62
P/E
0.00
Div yield
0.00%
More statistics
Low
60.15
High
62.87
Forward P/E
-8.52
Beta
1.29
Short ratio
4.40
Inst. own
111.07%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
61.60
200-d avg
57.04
1y target
117.30

5m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (134)
NameTimeAgo
SMA: BearishNov 2, 3:55 PM16 hours ago
SMA: BearishNov 2, 3:55 PM16 hours ago
SMA: BullishNov 2, 3:40 PM16 hours ago
SMA: BullishNov 2, 3:40 PM16 hours ago
SMA: BearishNov 2, 3:20 PM17 hours ago
SMA: BearishNov 2, 3:20 PM17 hours ago
SMA: BullishNov 2, 2:55 PM17 hours ago
MACD: Buy SignalNov 2, 2:55 PM17 hours ago
SMA: BullishNov 2, 2:50 PM17 hours ago
MACD: Sell SignalNov 2, 2:20 PM18 hours ago
SMA: BearishNov 2, 2:15 PM18 hours ago
SMA: BearishNov 2, 2:15 PM18 hours ago
SMA: BullishNov 2, 2:10 PM18 hours ago
SMA: BullishNov 2, 2:05 PM18 hours ago
MACD: Buy SignalNov 2, 2:05 PM18 hours ago
MACD: Sell SignalNov 2, 1:40 PM18 hours ago
SMA: BearishNov 2, 1:25 PM19 hours ago
SMA: BearishNov 2, 1:15 PM19 hours ago
SMA: BullishNov 2, 12:55 PM19 hours ago
SMA: BullishNov 2, 12:55 PM19 hours ago

Newest 20 of 134.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 117.30 +93.5% upside
Target (low)
75.00
Target (mean)
117.30
Target (high)
163.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy9
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 11
  • 2 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PCVX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-2.11-2.68 – -1.67-1.56-35.3%00.0%7
Next quarter-1.96-2.69 – -0.86-1.80-9.0%00.0%7
Current year-8.14-9.66 – -6.19-5.63-44.6%00.0%7
Next year-7.12-11.42 – -4.96-8.14+12.6%87.15M0.0%7

Upgrades and downgrades

The latest rating changes

PCVX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026Cantor FitzgeraldReiteratedOverweightOverweight
Oct 5, 2026BTIGReiteratedBuyBuy
Oct 5, 2026NeedhamMaintainedBuyBuy
Oct 5, 2026GuggenheimMaintainedBuyBuy
Sep 28, 2026B of A SecuritiesMaintainedBuyBuy
Sep 25, 2026NeedhamReiteratedBuyBuy
Feb 26, 2026BTIGMaintainedBuyBuy
Feb 2, 2026GuggenheimReiteratedBuyBuy
Nov 10, 2025BTIGReiteratedBuyBuy
Oct 16, 2025BTIGMaintainedBuyBuy
Sep 12, 2025Goldman SachsInitiated—Neutral
Apr 22, 2025Cantor FitzgeraldInitiated—Overweight
Apr 8, 2025NeedhamReiteratedBuyBuy
Apr 1, 2025Goldman SachsMaintainedBuyBuy
Apr 1, 2025B of A SecuritiesMaintainedBuyBuy
Apr 1, 2025NeedhamMaintainedBuyBuy
Mar 12, 2025GuggenheimReiteratedBuyBuy
Feb 26, 2025GuggenheimReiteratedBuyBuy
Feb 26, 2025NeedhamReiteratedBuyBuy
Feb 24, 2025BTIGReiteratedBuyBuy
Feb 11, 2025NeedhamReiteratedBuyBuy
Dec 24, 2024BTIGReiteratedBuyBuy
Dec 20, 2024Goldman SachsInitiated—Buy
Nov 6, 2024Cantor FitzgeraldReiterated—Overweight
Nov 6, 2024NeedhamReiteratedBuyBuy
Sep 10, 2024MizuhoMaintainedOutperformOutperform
Sep 4, 2024B of A SecuritiesMaintainedBuyBuy
Sep 3, 2024Leerink PartnersMaintainedOutperformOutperform
Sep 3, 2024JefferiesMaintainedBuyBuy
Sep 3, 2024NeedhamMaintainedBuyBuy